Children and Parents With ADHD and Related Disorders (ChiP-ARD)
|ClinicalTrials.gov Identifier: NCT01260792|
Recruitment Status : Completed
First Posted : December 15, 2010
Last Update Posted : March 26, 2012
Almost all rating scales for Attention-Deficit/Hyperactivity Disorder (ADHD) are not validated in France. This clearly hampers the development of the diagnosis and the monitoring of patients but also research in this domain. This study is conceived to collect data in the general population of children aged from 4 to 18 years in public schools in the city of Nice.
Children are pseudo-randomly selected from classes of randomly selected schools in the city of Nice (France). Teachers fill out questionnaires using a dedicated secured website, and ask parents to fill out a similar set of questionnaires regarding their child's behaviour at home. Since ADHD has a strong genetic components, parents are also asked to fill out questionnaires regarding their own behaviour at adulthood and in childhood retrospectively.
Additionally, known factors related to ADHD and other disorders as well as other putative factors are tested in the epidemiologic study.
|Condition or disease||Intervention/treatment|
|General Population TDAH Children Aged 5 to 18 Years||Other: questionnaire Other: Questionnaire|
|Study Type :||Observational|
|Actual Enrollment :||2600 participants|
|Official Title:||Validation and Norms for Attention Deficit/Hyperactivity Disorder Scales in Children and Adults. Description of Associated Factors.|
|Study Start Date :||February 2010|
|Actual Primary Completion Date :||July 2011|
|Actual Study Completion Date :||December 2011|
Children between 5 and 18 years old.
The teachers or the professors complete questionnaires on the child on their behavior in classes
Parents of children between 5 and 18 years old
The parents complete a questionnaire on the behavior of their child and on their own behavior
- Validity of studied instruments [ Time Frame: at time=0 ]The only criterion of evaluation towards the type of the study and its main objective is Validity of the studied instruments
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01260792
|CHU de Nice|
|Nice, France, 06000|
|Principal Investigator:||Hervé CACI, PH||CHU de Nice|